| 2025-11-14 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.03美元,归母净利润-918.4万美元,同比去年增长34.56%
|
| 2025-10-20 |
股东大会：
将于2025-12-03召开股东大会
会议内容 ▼▲
- 1.To elect 7 director nominees to the Company’s Board of Directors to hold office until the next Annual Meeting of Stockholders;
2.To ratify the appointment of HTL International, LLC. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025;
3.To provide an advisory vote on executive compensation.
4.Transact such other business as may properly come before the meeting and any adjournments or postponements of the meeting.
|
| 2025-08-28 |
详情>>
内部人交易：
Chan Heng Fai Ambrose股份减少130679.00股
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-0.78美元,归母净利润-692.9万美元,同比去年增长20.85%
|
| 2025-05-15 |
详情>>
股本变动：
变动后总股本909.25万股
变动原因 ▼▲
- 原因：
- From December 31, 2024 to March 31, 2025
Issuance of common stock for bonus
Stock based payments for professional services rendered
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-0.55美元,归母净利润-477.7万美元,同比去年增长-17.31%
|
| 2025-03-31 |
详情>>
业绩披露：
2024年年报每股收益-6.63美元,归母净利润-4689.6万美元,同比去年增长22.65%
|
| 2024-11-13 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.99美元,归母净利润-1403.4万美元,同比去年增长72.10%
|
| 2024-10-22 |
股东大会：
将于2024-12-04召开股东大会
会议内容 ▼▲
- 1.To elect 7 director nominees to the Company’s Board of Directors to hold office until the next Annual Meeting of Stockholders;
2.To ratify the appointment of Grassi & Co. Certified Public Accountants, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.To provide an advisory vote on executive compensation.
|
| 2024-10-22 |
详情>>
业绩披露：
2023年年报每股收益-8.67美元,归母净利润-6062.7万美元,同比去年增长-1.32%
|
| 2024-08-13 |
详情>>
业绩披露：
2024年中报每股收益-1.24美元,归母净利润-875.4万美元,同比去年增长80.95%
|
| 2024-05-14 |
详情>>
业绩披露：
2024年一季报每股收益-0.58美元,归母净利润-407.2万美元,同比去年增长49.32%
|
| 2024-01-05 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.36美元,归母净利润-5030.3万美元,同比去年增长-52.83%
|
| 2023-09-12 |
股东大会：
将于2023-10-25召开股东大会
会议内容 ▼▲
- 1.To elect 8 director nominees to the Company’s Board of Directors to hold office until the next Annual Meeting of Stockholders;
2.To ratify the appointment of Grassi & Co. Certified Public Accountants, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.To provide an advisory vote on executive compensation.
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益-0.33美元,归母净利润-4595.9万美元,同比去年增长-261.88%
|
| 2022-10-21 |
股东大会：
将于2022-12-06召开股东大会
会议内容 ▼▲
- 1.To elect 9 director nominees to the Company’s Board of Directors to hold office until the next Annual Meeting of Stockholders;
2.To ratify the appointment of Grassi & Co. Certified Public Accountants, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.To provide an advisory vote on executive compensation.
|
| 2022-04-15 |
股东大会：
将于2022-05-17召开股东大会
会议内容 ▼▲
- 1.To approve, the issuance of up to an aggregate of 17,570,948shares of the Company’s common stock to Alset EHome pursuant to the True Partner Transaction;
2.To approve, the issuance of up to an aggregate of 21,366,177 shares of the Company’s common stock to Alset International Limited pursuant to the AMRE Transaction;
3.To ratify the appointment of Turner, Stone & Company, L.L.P.as the Company’s independent registered public accounting firm for the fiscal years ending December 31, 2021 and December 31, 2022;
4.To approve the amendment of the Bylaws of DSS Inc. to change the quorum requirement from a majority of the stock issued and outstanding, either in person or by proxy, to at least thirty-five percent (35%) of the stock issued and outstanding, either in person or by proxy;
5.To approve an amendment to the Company’s Certificate of Amendment of Certificate of Incorporation, as amended (the “Certificate of Incorporation”) to increase the total number of shares of the Company’s authorized common stock to 500,000,000;
6.To approve an amendment to the 2020 Employee, Director and Consultant Equity Incentive Plan (“2020 Equity Incentive Plan”) to increase the number of shares of common stock authorized to be issued pursuant to the 2020 Plan to 20,000,000 shares.
7.To approve the issuance of up to an aggregate of 15,389,995 shares of the Company’s common stock to Mr. Heng Fai Ambrose Chan pursuant to his employment agreement.
|
| 2022-01-26 |
复牌提示：
2022-01-25 15:16:41 停牌，复牌日期 2022-01-25 16:00:00
|
| 2021-10-01 |
股东大会：
将于2021-11-09召开股东大会
会议内容 ▼▲
- 1.To elect seven director nominees to the Company’s Board of Directors to hold office until the next Annual Meeting of Stockholders;
2.To ratify the appointment of Freed Maxick CPAs, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021;
3.To provide an advisory vote on executive compensation.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-11-02 |
股东大会：
将于2020-12-08召开股东大会
会议内容 ▼▲
- 1.To elect eight director nominees to the Company’s Board of Directors to hold office until the next Annual Meeting of Stockholders;
2.To ratify Freed Maxick CPAs, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020;
3.To provide an advisory vote on executive compensation;
4.To approve, pursuant to Rule 713 of the NYSE American, the potential issuance of shares of the Corporation’s common stock, par value $0.02 per share. representing equal to or greater than 20% or more of presently outstanding stock, issuable upon conversion of our Series A Convertible Preferred Stock, issued by the Company to Global BioMedical Pte. Ltd on August 21, 2020 in accordance with the Share Exchange Agreement dated April 27, 2020, by increasing the beneficial ownership limitation of the Series A Convertible Preferred Stock;
5.To approve the reincorporation of the Company from New York to Texas, pursuant to a merger of the Company with and into a newly-formed Texas corporation that will initially be a wholly-owned subsidiary of the Company, resulting in a change in name of the Company from “Document Security Systems, Inc.” to “Alset, Inc.”
|
| 2020-07-14 |
股东大会：
将于2020-08-10召开股东大会
会议内容 ▼▲
- 1.To approve the issuance of shares of DSS Common Stock and Series A Preferred Stock in connection with the acquisition of Impact BioMedical Inc., pursuant to the Share Exchange Agreement, a copy of which is attached as Appendix A to the accompanying proxy statement.
2.To authorize an adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes in favor of Proposal 1;
3.To ratify the approval by our Board of Directors of an amendment to our bylaws to allow for participation in stockholder meetings by means of virtual meeting technology;
4.Transacting such other business as may properly come before the meeting or any adjournment thereof.
|
| 2020-05-08 |
详情>>
拆分方案：
每30.0000合并分成1.0000股
|
| 2020-03-27 |
股东大会：
将于2020-05-04召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our certificate of incorporation to effect a reverse split of our common stock by a ratio of 1-for-30 (the “Reverse Split”); 2.Transacting such other business as may properly come before the meeting or any adjournment thereof.
|
| 2019-11-15 |
股东大会：
将于2019-12-09召开股东大会
会议内容 ▼▲
- 1.Electing seven directors to the Company’s Board of Directors;
2.Ratifying the appointment of Freed Maxick CPAs, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019;
3.Approving the Company’s 2020 Equity Incentive Plan (the “2020 Incentive Plan”);
4.Conducting an advisory vote on executive compensation;
5.Conducting an advisory vote on the frequency of future advisory votes on executive compensation;
6.Transacting such other business as may properly come before the meeting or any adjournment thereof.
|
| 2018-04-18 |
股东大会：
将于2018-06-01召开股东大会
会议内容 ▼▲
- 1.Considering and voting upon a proposal to elect nine directors to the Company’s Board of Directors to hold office until the next Annual Meeting;
2.Considering and voting upon a proposal to ratify Freed Maxick CPAs, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018;
3.Conducting an advisory vote on executive compensation;
4.To transact such other business as may properly come before the meeting or any adjournment thereof.
|
| 2017-06-20 |
股东大会：
将于2017-08-01召开股东大会
会议内容 ▼▲
- 1.Considering and voting upon a proposal to elect nine directors to the Company’s Board of Directors to hold office until the next Annual Meeting;
2.Considering and voting upon a proposal to ratify Freed Maxick CPAs, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017;
3.Conducting an advisory vote on executive compensation;
4.To transact such other business as may properly come before the meeting or any adjournment thereof.
|
| 2016-08-11 |
详情>>
拆分方案：
每4.0000合并分成1.0000股
|
| 2016-04-29 |
股东大会：
将于2016-07-19召开股东大会
会议内容 ▼▲
- 1. Considering and voting upon a proposal to elect six directors to the Company’s Board of Directors to hold office until the next Annual Meeting;
2. Considering and voting upon a proposal to ratify Freed Maxick CPAs, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016;
3. Conducting an advisory vote on executive compensation;
4. Approving an amendment to the Company’s Certificate of Incorporation to effect a 1-for-4 reverse stock split;
5. To transact such other business as may properly come before the meeting or any adjournment thereof.
|